will tirzepatide lower a1c How Helps Lose Weight & Improve Metabolic Health Tirzepatide: A Novel Glucose-Dependent Insulinotropic
Description
The SURPASS-1 to -5 clinical trials assessed the efficacy of once weekly tirzepatide (5, 10 and 15 mg) versus placebo or active comparators (semaglutide 1 mg, insulin degludec and insulin glargine) in T2D
This article covers mechanism, clinical trial evidence, FDA-approved indications, boxed-warning safety, and the FTO, GLP1R, MC4R, and TCF7L2 variants that shape every GLP-1 response
Whats new in the NEJM paper (vs the topline release)
#ObesityCare #GLP1 #Semaglutide #STEPUP #ObesityMedicine | 20 comments on LinkedIn
This can be both a serious and common side effect
